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An overview of optical biomolecular imaging is provided. Following a brief history of the development 5 
of probes and technologies in this area, general approaches used image biomolecules in current 
commercial systems are discussed.  A brief summary of research challenges in this area – in terms of both 
the chemistry and technique development - is introduced. Finally, areas rich for possible future 
development are suggested. 
Introduction 10 
Attributed to the Apostle St Thomas, the familiar phrase “Seeing 
is believing”, is the philosophical basis of all sensor and image 
probe technologies. Although, the design of synthetic, molecular-
based, targeted sensors only really emerged as a clear research 
discipline in the last few decades, as is often the case, Nature got 15 
there first.  
 Research into the molecular basis of the five senses has 
revealed the exquisite sensitivity of these biological systems: a 
rod cell within the eye can detect a single photon, olefactory 
receptors (which, interestingly, can only detect molecules with 20 
molecular weights below 300 Da1) can immediately detect the 
presence of specific chemical functional groups, and the 
mechanoreceptors of the human cochlea can detect sound driven 
vibrations of only 0.3 nm and differentiate 1 Hz differences in 
tones pitched at around 1000 Hz.2 In fact, cellular functions 25 
throughout the cell cycle are predicated on a complex network of 
signalling systems triggered by the detection of specific 
molecular substrates that consequently up- or down-regulate 
biological pathways and events.  
 In all these natural biological sensor systems the same protocol 30 
is used: Perception, Signal Transduction, and Response – a 
sequence that has become familiar in the design of synthetic 
systems. While the generation of intentionally designed small ion 
and molecule sensors following these principles has greatly relied 
on developments of specific macrocycles, optical imaging probes 35 
for cellular components and biomolecules have a much longer 
history.  
Optical microscopy stains – a brief history 
Since most cells are transparent and largely colourless, detailed 
cellular studies could only truly begin after the development of 40 
differential cell stains; this process began in earnest in 1858 when 
Joseph von Gerlach outlined how dilute solutions of carmine 
could be preferentially taken up by, and stain, the nuclei of brain 
tissue cells. 3 In the following decades, a number of significant 
breakthroughs in this area were made. Despite the fact that most 45 
stains were generally non-specific, and had affinities only for 
certain broad categories of molecules - such as proteins, nucleic 
acids, or lipids - several imaging protocols developed in this 
period are still important today.  
 Notably, Hans Christian Gram delineated the staining 50 
methodology that bears his name. Gram staining - which is still 
used as one of the first steps in classifying bacteria - relies on the 
fact that, whilst the purple stain crystal violet is retained in 
peptidoglycan-rich cell walls of Gram-positive bacteria, a 
counterstain is required to image Gram-negative strains. 4  55 
 Perhaps more remarkably, one of the cell staining systems 
developed during this early period of discovery, over a century 
ago, 5 is still the most commonly used imaging agent for medical 
diagnostics.  
 60 
Fig. 1 H&E staining used in a lung biopsy of a SARS patient - arrow 
marks an enlarged pneumocyte. Image from Nichols et al, 6 with 
permission from Elsevier. 
 As its name implies, the haematoxylin and eosin, H&E, stain is 
a combination of two stains. Haematoxylin, which is a derivative 65 
of the Central American logwood tree, is the only natural product 
stain still commonly in use.  When haematoxylin is dissolved in 
water and oxidised, addition of Al3+ ions produces haemalum, a 
dye that stains nucleic acids blue. The second component of 
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H&E, eosin, is a general counterstain that produces red and pink 
colours when it non-specifically binds to proteins.  
 Although the use of H&E was first described almost 140 years 
ago, it is still considered to be “the standard morphological 
staining method for just about every histological laboratory in 5 
the world” 7 and is used millions of times a day in general 
histology and cancer diagnosis - see Fig 1. 
 Apart from the fact that classical stains like those used in the 
Gram and H&E protocols are generalized stains with low 
selectivities against specific biomolecules, they image cellular 10 
structures through absorbing transmitted light and thus the 
contrast they provide is finite. In contrast, luminescent dyes can 
theoretically provide infinite contrast, thus potentially providing 
an advantage of higher sensitivity and image resolution. 
Consequently, following the introduction of fluorescence-based 15 
microscopes in the early twentieth century and the identification 
of many luminescent dyes for specific biomolecules and cellular 
structures, this became the preferential optically-based 
microscopy technique. 8  
 In the twenty-first century, research in cytology, molecular 20 
biology, and medicine and diagnostics has become more and 
more reliant on optical microscopy and as new techniques are 
developed, this trend can only continue. Furthermore, the desire 
to move from non- or low specificity stains of tissues and cells to 
optical probes designed to bind to intracellular targets with high 25 
specificity has motivated much research in this area.  
 Taken together the reviews in this special issue present 
detailed snap-shots of the present state of play in many aspects of 
research in this rapidly expanding area. This article provides a 
brief curtain-raising introduction into some general aspects of this 30 
area.  
Biomolecular probes – general design principles 
Broadly speaking, two main approaches have been employed in 
the construction of these systems. In one approach luminescent 
small molecules have been designed intrinsically to bind target 35 
biomolecules, whilst the second approach involves hybrid 
systems where photoactive moieties are attached to molecules or 
macromolecules that recognize the defined target.  
Established small molecule fluorescence probes for 
biomolecules 40 
  Due to their pivotal roles in biological processes, a range of 
imaging systems for RNA and DNA in live cells has been 
developed. The Hoechst, SYTO and DRAQ series of stains typify 
small luminescent molecules commercially developed for these 
applications. They are all taken up by live cells, interact with, and 45 
allow for imaging of nucleic acids through two major binding 
motifs. 9 The central fused rigid tricyclic structure of the 
anthroquinone derivative DRAQ5 is typical of an intercalating 
moiety, which inserts between base-pairs. In contrast, the 
bis(benzimidazoles) Hoechst dyes such as H33258 bind to 50 
nucleic acids through minor groove binding. A very wide range 
of cyanine-based luminescence probes has been used to image 
nucleic acids. Although some cyanine probes, such as the cell-
impermeant dyes TO and TOTO, are known to be intercalators, 
the SYTO systems are – like the Hoechst dyes - minor groove 55 
binders. 10  
 Lipid structures can be imaged through labelling of specific 
lipid molecules, for example the fluorescent Cholera Toxin B 
subunit can be attached to GM1 lipids. 11 Lipids can also be  
selectively imaged using small molecules; although a range of 60 
probes has been used, the properties of the dye 6-acyl-2-
dimethylaminonapthalene, Laurdan, make it particularly suited 
towards this task as it displays polarity-sensitive 
solvatochromism. Notably, since a 50 nm blue-shift is observed 
in dye emission on moving from a polar (liquid disordered) to 65 
nonpolar (liquid ordered) environment, this phenomenon can be 
used to probe ratiometrically ordering within the lipid membranes 
of living cells and vertebrae organisms. 12   
 
Fig. 2 Examples of common, commercially available, small molecules 70 
probes for biomolecules. DRAQ5 (top) is a DNA intercalator; whereas 
H33258 (middle) is a DNA groove binder. Laurdan (bottom) is used to 
image lipid-rich structures such as membranes. 
 Compared to nucleic acids and lipids, carbohydrates and 
proteins have a very much greater structural diversity and this 75 
means that general small-molecule-based cellular imaging probes 
for these biomolecules are not widely available; 13 although, as a 
number of reviews in this special edition illustrate, approaches 
towards these goals are rapidly making progress. 
Hybrid fluorescence probes methods for biomolecules 80 
In the case of nucleic acid imaging, this second approach 
encompasses several methods involving in situ hybridization. 14 
Fluorescence in situ hybridization, (FISH) exploits the ability of 
complementary oligonucleotide sequences to recognize each 
other. 15 In FISH, a luminescent moiety is attached to a single 85 
stranded oligonucleotide that is complementary to a specific 
target sequence. By using a combination of fluorophores multiple 
sequences can be targeted; so, for example, FISH has been used 
to visualize gene transcription simultaneously at multiple sites 
within a single fixed cell nucleus. 16 90 
 In situ hybridization has also been used to construct 
fluorescence resonance energy transfer, FRET, probes. In this 
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case, two oligonucleotides designed to hybridize to adjacent 
regions on a nucleic acid target sequences are labelled with donor 
and acceptor fluorophores at the 5’ and 3’ ends respectively. As 
luminescence is only generated when both probes hybridize to the 
target, FRET methods enhance signal-to-noise as no output is 5 
generated by unbound probes. 17 A related phenomenon is 
exploited in the nucleotide-based imaging probes known as 
molecular beacons. In this case a single probe sequence that 
forms a stem-loop oligonucleotide hairpin is employed. One end 
of the sequence is appended with a fluorophore and the other with 10 
a quencher moiety. In the folded hairpin these two tethered units 
are held in proximity and luminescence is suppressed. On 
hybridization to the target sequence the fluorophore-quencher 
pair is separated and emission is “switched-on.” 18 These systems 
not only offer high signal-to-noise ratios, but – because they are 15 
initially hairpin structures that only linearise through a 
competitive hybridization to a target sequence - they exhibit a 
higher specificity for perfectly complementary nucleic acid 
targets compared to conventional linear oligonucleotides. 
Consequently, molecular beacons are the most widely adopted 20 
class of nucleotide-based probes for live-cell imaging, but 
because DNA is relatively inaccessible for hybridization as it is 
found as a duplex packed into the nuclear chromatin structure, 
this technique is predominantly employed in RNA imaging. 
 The major problem with these nucleotide-based methods is 25 
poor cellular penetration: nucleotides are polyanionic hydrophilic 
macromolecules that do not readily permeate cellular membranes, 
therefore such systems have to be microinjected into individual 
cells or delivered using other mechanical or chemically-based 
transfection techniques. Similar hybrid systems for DNA 30 
imaging, for example involving antibody targeting systems or 
fluorescent proteins, commonly present similar delivery 
problems. 
 
Fig. 3 Fixed HeLa cells stained through the parallel application of a range 35 
of targeting methods and fluorophores. HeLa cells transfected with GFP–
a-tubulin and tetracysteine–b-actin were stained with ReAsH. After 
fixation, cells were immunolabeled for the Golgi matrix protein giantin 
with quantum dots and for the mitochondrial enzyme cytochrome c with 
Cy5. DNA was stained with Hoechst 33342.Scale bars, 20 µm. Image 40 
from Giepmans et al,19 with permission from the American Association 
for the Advancement of Science. 
 Protein imaging is dominated by two hybrid approaches. In 
immunolabelling, small molecule dyes are attached to primary or 
secondary antibodies. 19 However, again, this technique is largely 45 
restricted to permeabilised cells or proteins that are compatible 
with endocytosis. With the identification of green fluorescence 
proteins (GFP) and related fluorophores, the second approach - of 
genetically encoding GFP, or one of its variants, as a fusion to the 
target protein or gycoprotein within a cell – is the default method 50 
of protein labelling. Nevertheless, despite the power of this 
method, due to the significant size of FPs, there is always the 
possibility that the fusion may interfere with endogenous protein 
function. 
 As illustrated by Figure 3, by using a range of currently 55 
available optical probes, some impressively detailed images of 
intracellular components can be obtained. However, as outlined 
in the next section, there are still many aspects of cell structure 
and dynamics that are not so readily imaged. Furthermore, as 
microscope technologies are developing probes with specific 60 
optical properties are also required 
Current challenges 
The reviews in this special edition will illustrate in more detail 
the following issues that shows that current research involves 
both extending the range of biomolecules that can be imaged and 65 
the output modalities.  
Improving biomolecular targeting 
 As can be seen from the previous brief - and far from 
comprehensive – précis, certain classes of biomolecules are 
poorly served by existing imaging technologies. In particular it is 70 
clear that, due to their diversity and their composition from 
largely aliphatic components, probes for carbohydrates are a 
current challenge and have not been developed to the extent of 
other classes of biologically important molecules. Clearly, if 
these challenges can be met, this is an area with much potential 75 
for exciting development. There are a number of other areas 
where imaging probes are still lacking. For example, although 
nucleic acid probes are established, optical imaging probes for the 
wide range of biologically active monomeric nucleotide 
structures are less well developed. 80 
 In ground-breaking work, the Hamachi group has reported on 
ZnII-complexes as in-cellulo luminescent probes for ATP and 
related molecules 20. However, despite their vital biological roles, 
selective cell probes for specific nucleotides, such as the cyclic 
nucleotide-based secondary messengers (eg cAMP, cGMP), are 85 
not readily available. Indeed, generally speaking, research into 
optical probes for all signalling molecules is potentially another 
area for future growth.  
 In the shorter term, targeting capabilities over available probes 
can still be improved; nucleic acid provide a case in point. 90 
Although, as outlined, general probes for both DNA and RNA are 
now readily available, substantial proportion of current research 
in this area is centred on visualizing nucleic acids at the 
sequence/structure level. This would be a hugely attractive 
prospect; for example, specific sequences and non-canonical 95 
structures, such as quadruplexes, are associated with particular 
disease states, including cancer. To image such structures in live 
cells or even in vivo will facilitate insights into the detailed 
dynamic mechanisms of their (dys)functions, and also provide the 
basis of new convenient optically-based medical diagnostic 100 
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methods.  
Improving optical properties 
The majority of commercial optical probes rely on simple 
emission intensities to locate target structures. There are 
disadvantages to this approach that are being addressed through a 5 
number of approaches. 
Ratiometric sensing of biomolecules 
Conventional emission sensing relies on “off-on” switching of 
luminescence intensity. However. ratiometric probes - which 
commonly exploit analyte-induce changes in the ratio of emission 10 
intensities at two different wavelengths -  are hugely more 
convenient.  As the probe response is independent of its 
concentration, analyte concentrations can be quantitative 
determined irrespective of probe concentration. 
 The impact of this concept, first described by Tsien and co-15 
workers in a 1985 paper on Ca2+ sensing, 21 is reflected by the 
fact that their original study is one of the top 50 most cited papers 
in science with over 20,000 current citations. 22 As a 
consequence, reports on ratiometric sensors for cations and 
anions now abound, with many of these systems functioning 20 
within live cells. In contrast, in cellulo ratiometric sensors for 
biomolecules are considerably less common.  
Two photon Absorption 
Commonly, commercial fluorescent dyes used in live cell 
imaging are photoexcited by relatively high-energy light (350 – 25 
450 nm); such energies are, in themselves, deleterious to cells as 
they can irreversibly damage DNA and generate cytotoxic 
reactive oxygen species, ROS. Furthermore, due to the presence 
of endogenous chromophores, cells and tissues only show 
maximum transparency in a “biological optical window” of 650 30 
to 1350 nm, meaning that traditional optical microscopy is 
restricted to depths of 100 µm. For both these reasons, dyes that 
are photoexcited in the red/infrared region are being sought. In 
these circumstances depth penetrations of up to a millimetre can 
be achieved, allowing deep optical imaging of tissues rather than 35 
2-D cell cultures. This can be accomplished using dyes that are 
photoexcited through two photon absorption, 2PA. 23  
 The 2PA process allows access to an excited state using 
photons of half the energy (or twice the wavelength) of the usual 
one-photon excitation. Broadly, a dipolar dye with an extended π-40 
delocalized bridge will have enhanced 2PA properties.24 A 
second advantage of using 2PA is that it provides enhanced 
imaging resolution. Compared to a conventional one photon 
system, emission from a 2PA dye is highly dependent on incident 
light intensity (quadratic vs linear dependency), therefore all out-45 
of-focus emission is supressed, this also means that dye 
photobleaching is greatly reduced. 25  
 Although the irradiating energy used in these techniques is 
lower than conventional methods, the overall laser power used 
can be considerably higher and this may potentially lead to 50 
photodamage in itself. This problem can be circumnavigated 
through the use of pulsed laser sources. 
 Although a number of readily available probes are already 
used in this form of microscopy, commercial systems generally 
have low 2PA cross-sections or poor photostabilities in the 55 
required conditions, therefore there is still a need to develop new 
2PA probes with enhanced optical and intracellular targeting 
properties.  
Lifetime emission probes 
Techniques based on the emission lifetime of a bioprobe offer a 60 
number of advantages compared to conventional emission 
wavelength/intensity-based microscopy. For example, in lifetime 
imaging microscopy, LIM, the optical output of a probe is 
independent of probe concentration or incident light intensities, 
the use of fluorescent and phosphorescent dyes with lifetime well 65 
above those of endogenous flourophores negates interference due 
to autofluorescence from endogenoous fluorophores, additionally 
- assuming a difference in lifetimes - LIM can be used to 
distinguish multiple fluorophores with overlapping emission 
wavelengths. Furthermore, since emission decay is often 70 
dependent on physical properties, such as local viscosity, pH, or 
oxygen concentrations, LIM can provide information on the 
micro-environment of the probe itself. 26 
 Despite these advantages compared to conventional 
technologies, it is only thanks to the recent increased availability 75 
of commercial instruments that research into LIM has begun to 
develop rapidly in the last decade. Whilst much research in this 
area still involves improving instrumentation, new LIM-
compatible probes for specific biomolecules are also required; in 
particular, longer lifetime probes are being sought as this allows 80 
for increased environmental sensitivity, for example towards 
oxygen concentration mapping or FRET effects.  
 One possible disadvantage of LIM is that any electron or 
energy transfer process can competitively deactivate the emissive 
state, so imaging of specific targets can be affected by the 85 
presence of common species such as the aforementioned oxygen, 
as well as specific endogenous fluorophores.  
Breaking the diffraction limit 
Until relatively recent, all forms of optically based microscopy 
suffered from a spatial resolution barrier. In 1835 Airey described 90 
circular distortions caused by closely spaced points - now known 
as Airey discs - that occur due to light diffraction at the lens 
aperture.  Around 40 years later, Abbé mathematically defined 
the diffraction limit (d) for imaging at a given wavelength (λ) of 
light in a medium of refractive index (n) as d = λ/2n(sinθ), where 95 
θ is the angle defined by the cone of focussed light. This 
relationship means that in conventional optical microscopy, 
spatial resolution – the largest distance at which the image of two 
point-like objects seems to merge - is restricted approximately to 
half the wavelength of the imaging light. 27 Therefore, shorter 100 
wavelength light produces better resolution than longer 
wavelength light. However, as explained above, high-energy light 
is deleterious to cells. So, in practise, resolution is normally 
restricted to features above 200 – 250 nm.  However, in the last 
decade a number of techniques, collectively known as super-105 
resolution microscopy, SRM, have emerged that allow this 
diffraction barrier to be broken. 
 Super resolution can be achieved by exploiting the intrinsic 
emission properties of specific probes and/or through 
sophisticated data-processing algorithms. These concepts are 110 
illustrated by examples 
 In a technique such as structured illumination microscopy 
(SIM), probes that are photostable throughout image collection 
are required, so many existing conventional optical probes are 
suited to these technologies. In SIM a periodic illumination 115 
pattern is projected onto a sample and then a set of images are 
recorded after translation and rotation of this mask pattern. Super 
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resolution is then achieved through a post-collection 
mathematical data analysis. 28 Using specific illumination 
sequences, 2-D resolutions down to 50 nm can be obtained, 
furthermore image collection speeds are also suitable for dynamic 
live cell imaging. 29 In contrast to the image processing approach 5 
of SIM, most other SRM technologies are also reliant on 
stochastic emission from single probe molecules. Perhaps the best 
know approach exploiting this concept is stochastic optical 
reconstruction microscopy, STORM. 
 Techniques such as STORM, are dependant on luminophores 10 
that can switch between emissive ON and non-emissive OFF 
states during image collection. In the STORM experiment at any 
given moment only a small fraction of probes are in the ON state, 
thus emission from individual molecules is highly likely to be 
spaced out further than the resolution limit. The positions of these 15 
outputs are then precisely defined by fitting to a point-spread 
function. Through collection of a stacked series of images, a 
combined map - typically incorporating the position of 104 - 107 
single probe molecules in the ON state as “pixels” - a final 
pointillistic super-resolution image is constructed. 30  20 
 
Fig. 4 A comparison of conventional and STORM imaging. (A) 
Conventional immunofluorescence image of microtubules in a large area 
of a BS-C-1 cell. (B) STORM image of the same area. (C and E) 
Conventional and (D and F) STORM images corresponding to the boxed 25 
regions in (A). Image adapted from Bates et al, 31 with permission from 
the American Association for the Advancement of Science. 
 
 Due to its specific requirements, STORM is driving the 
development of new molecular probes. Probes with high quantum 30 
yields but short lifetimes are needed to supply ON/OFF blinking. 
This was initially accomplished through the use of photo- or 
redox switched systems. More recently dSTORM (direct 
STORM), in which bright probes switch to dark charge-transfer 
or triplet states, has facilitated the use of conventional dyes in this 35 
super-resolution technique. 32 However this technique can 
potentially yield reactive oxygen species that will enhance 
cellular photodamage 
 Although SRM has developed at a fierce rate in the last 
decade, challenges still remain; for example, resolution in three-40 
dimension needs to be improved, whilst the development of 2PA-
STORM probes will allow live super-resolution imaging over 
longer time frames and at greater depth.  
Outlook 
As Neils Bohr is reputed to have stated; “Prediction is very 45 
difficult, especially about the future.” Nevertheless, it does seem 
clear, that several aspects of this research are ripe for further 
development. Therefore - paradigm-changing breakthroughs 
aside - I offer some personal, far from complete, suggestions for 
current areas that provide promise for the future. 50 
 A general trend in optical microscopy is increased specificity 
and resolution; already many cell types, and sub-cellular 
compartments can be selectively imaged and in some cases 
specifc proteins and nucleic acid strucures - and sub-structures - 
have already been targeted. In the future, this work will be 55 
extended so that these molecules as well as carbohydrates and 
glycoproteins can  be imaged within a defined compartment. 
 The photophysical and chemical properties of metal complexes 
make them well suited to several of the emerging applications 
discussed above. For example, due to their distinctive 60 
coordination geometries, and the diversity of their excited states, 
d8, and d6-metal centre33 as well as lanthanide complexes34,35 are 
forming the basis of an increasing number of optical probes for 
biomolecules and biomacromolecules.  
 These species quite often display emission from triplet states 65 
(formally phosphorescence) and thus have large Stokes shifts and 
long lived luminescence. In conventional emission-based optical 
microscopy these properties are useful for enhancing signal/noise 
ratios through time-gating image collection, but it also makes 
them appropriate starting points for the development of live-time 70 
probes for LIM. Indeed, given that metal complexes for 
conventional time-gated confocal microscopy and LIM are 
already becoming commercially available, it seems research in 
this area is ripe for further development. The dipolar nature of 
metal-to-ligand charge-transfer, MLCT, excited states in d-metal 75 
based also suggests that they have great potential for 2PA 
microscopy as well: certainly MLCT has been successfully 
exploited in systems displaying other nonlinear optic effects.  
 In recent years, nanoparticles - particularly quantum dots 
(QDs) and gold nanoparticles (AuNPs) - have attracted increasing 80 
attention as potential bioprobes 36 and bioimaging agents. 37 QDs 
are resistant to photobleaching, display high quantum yields and 
absorbances, and have tunable sharp emission energies, which 
can potentially be exploited in multiplexing.  
 Despite these appealing properties, significant stumbling 85 
blocks to the routine use of QDs as optical probes for 
biomolecules remain, in particular - due to their size - uptake by 
living cells is restricted and there are concerns about their 
toxicity.  Furthermore while the attachment of macromolecular 
targeting moieties - such as antibodies - to QDs is now routine, 90 
specific targeting has not always been accomplished. In 
particular,  the use of anchored small molecules target specific 
receptors is still much less developed. 
 AuNPs possess many of advantages of QDs however and 
although their optical properties are currently not so versatile, 95 
approaches to address this issue are beginning to emerge. 
Nevertheless, there is no doubt that - as these challenges are met - 
nanoparticles will provide new tools for optical microscopy. 
 One emerging area that also seems set to grow in importance is 
the identification and synthesis of multimodal imaging probes. As 100 
more and more technologies for imaging at the cellular and 
subcellular scale are developed, the possibility of visualizing 
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living systems with multiple/complementary technologies is 
becoming increasingly achievable. This approach, will not only 
provide “orthogonal” evidence of targeting to specific 
biomolecules, but also provide dynamic information at a range of 
sensitivities, tissue depths, and resolutions.  5 
Finally, although the term theranostics was coined over 10 
years ago 38 to describe molecular systems that could 
simultaneously provide diagnostic imaging and therapy - and has 
since been much discussed in the introductory paragraph of many 
papers - up until recently, many new probes that have been put 10 
forward as examples of this concept are just luminescent 
analogues of extant therapeutics and therapeutic leads that do not 
provide real diagnostic insight. However, even in the shorter 
term, this is an achievable target for a number of therapeutic 
regimes. For example, photodynamic therapy fundamentally 15 
requires photo-excitable molecules as sensitizers, which ideally 
localize in therapeutic targets. It requires virtually no re-
engineering to create theranostic systems from this treatment 
method; although for reasons of penetration depth 2PA systems 
will be required. In the longer term, technologies for several 20 
developing therapeutic areas - such as vectors for gene delivery 
and systems that target cell death – offer great potential for real 
theranostics. This is an area where the potential versatility of 
functionalized nanoparticles offer great promise.  
 Given that future commercial demands for new biological and 25 
medical imaging agents is predicted to increase considerably, it 
seems the explosion of research interest in this area over the last 
decade of so will continue well into the foreseeable future. The 
reviews in this special issue provide authoritative snapshots of the 
state-of-the-art in this multidisciplinary research subject. 30 
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